Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ANGLE plc stock logo
ANPCY
ANGLE
C$0.87
+22.1%
C$0.94
C$0.62
C$2.39
N/AN/A1,368 shs375 shs
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
$0.16
-11.8%
$0.14
$0.10
$2.90
N/AN/A8,930 shs150 shs
Epigenomics AG stock logo
EPGNY
Epigenomics
$2.39
$2.39
$2.01
$2.39
N/AN/A100 shsN/A
Integrated Diagnostics Holdings plc stock logo
IDGXF
Integrated Diagnostics
$0.32
$0.32
$0.28
$0.42
N/AN/A5,300 shsN/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ANGLE plc stock logo
ANPCY
ANGLE
+16.03%-24.03%-26.13%-27.94%-70.73%
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
-14.00%+24.80%+5.41%-18.75%-77.71%
Epigenomics AG stock logo
EPGNY
Epigenomics
0.00%0.00%0.00%0.00%0.00%
Integrated Diagnostics Holdings plc stock logo
IDGXF
Integrated Diagnostics
0.00%0.00%0.00%-0.62%+3.90%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ANGLE plc stock logo
ANPCY
ANGLE
N/AN/AN/AN/AN/AN/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Epigenomics AG stock logo
EPGNY
Epigenomics
N/AN/AN/AN/AN/AN/AN/AN/A
Integrated Diagnostics Holdings plc stock logo
IDGXF
Integrated Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ANGLE plc stock logo
ANPCY
ANGLE
0.00
N/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
0.00
N/AN/AN/A
Epigenomics AG stock logo
EPGNY
Epigenomics
0.00
N/AN/AN/A
Integrated Diagnostics Holdings plc stock logo
IDGXF
Integrated Diagnostics
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ANGLE plc stock logo
ANPCY
ANGLE
N/AN/AN/AN/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
$8.81MN/AN/AN/AN/AN/A
Epigenomics AG stock logo
EPGNY
Epigenomics
N/AN/AN/AN/AN/AN/A
Integrated Diagnostics Holdings plc stock logo
IDGXF
Integrated Diagnostics
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ANGLE plc stock logo
ANPCY
ANGLE
N/A-C$0.48N/AN/AN/AN/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/AN/A0.00N/AN/AN/AN/AN/A
Epigenomics AG stock logo
EPGNY
Epigenomics
N/A-$3.05N/AN/AN/AN/AN/AN/A
Integrated Diagnostics Holdings plc stock logo
IDGXF
Integrated Diagnostics
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ANGLE plc stock logo
ANPCY
ANGLE
N/AN/AN/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/AN/AN/AN/AN/A
Epigenomics AG stock logo
EPGNY
Epigenomics
N/AN/AN/AN/AN/A
Integrated Diagnostics Holdings plc stock logo
IDGXF
Integrated Diagnostics
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
ANGLE plc stock logo
ANPCY
ANGLE
N/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/A
Epigenomics AG stock logo
EPGNY
Epigenomics
N/A
Integrated Diagnostics Holdings plc stock logo
IDGXF
Integrated Diagnostics
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ANGLE plc stock logo
ANPCY
ANGLE
173N/AN/ANot Optionable
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
10N/AN/ANot Optionable
Epigenomics AG stock logo
EPGNY
Epigenomics
32N/AN/ANot Optionable
Integrated Diagnostics Holdings plc stock logo
IDGXF
Integrated Diagnostics
6,692N/AN/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

ANGLE stock logo

ANGLE OTCMKTS:ANPCY

C$0.87 +0.16 (+22.09%)
As of 03:00 PM Eastern

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.

bioAffinity Technologies stock logo

bioAffinity Technologies NASDAQ:BIAFW

$0.16 -0.03 (-14.00%)
As of 03:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

Epigenomics stock logo

Epigenomics OTCMKTS:EPGNY

$2.39 0.00 (0.00%)
As of 04/6/2023

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

Integrated Diagnostics stock logo

Integrated Diagnostics OTCMKTS:IDGXF

$0.32 0.00 (0.00%)
As of 07/16/2025

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, including positron emission tomography computed tomography (PET-CT), magnetic resonance imaging (MRI), computed tomography (CT), mammography, ultrasound, x-ray, electromyography (EMG), electroencephalography, electroencephalogram (EEG), and electrocardiogram (ECG), as well as operates cath lab facilities. It operates in Egypt, Sudan, Jordan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.